Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
[3] In another research study it was hypothesized that BPC-157 may have led to an acceleration in wound closure compared to the control group via an improvement in the formation of granulation tissue, reepithelialization, dermal remodeling, and collagen deposition
Both medications have minimal side effects, mostly involving minor digestive upset or injection site reactions
Genesis Peptides makes no claims regarding human clinical efficacy
GM-CSF, granulocyte-macrophage colony stimulating factor
[1] [3] These injections are prescription-only medicines (POMs) typically prescribed by GPs for patients with confirmed B12 deficiency
70 HP 130 BPC-157 Pentadecapeptide Cytoprotection ALIASES BPC157, Body Protection Compound 157, PL 14736, pentadecapeptide CLASS Synthetic 15-amino-acid peptide gastric-origin fragment FORMULA C62H98N16O22 SEQUENCE Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val HALF-LIFE ~4 hours (rat, intraperitoneal) ROUTES Subcutaneous Intraperitoneal Oral (animal studies) MECHANISM OF ACTION Synthetic 15-amino-acid fragment of a gastric protective protein
